Previous close | 1.8800 |
Open | 1.8500 |
Bid | 1.5900 x N/A |
Ask | 1.6200 x N/A |
Day's range | 1.6600 - 1.8700 |
52-week range | 1.0100 - 2.7800 |
Volume | |
Avg. volume | 37 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights Given the large stake in the stock by institutions, Regulus Therapeutics' stock price might be vulnerable...
Financial and Clinical Progress Amidst Net Loss Wider Than Estimates
Amylyx Pharmaceuticals (AMLX) and Acadia Pharmaceuticals (ACAD) plunged on failure of studies.